Requirements for Adaptive Designs in Clinical Trials

| 01 June 2009

The interest in adaptive trial design has rapidly increased within the pharmaceutical industry in recent years. Furthermore, regulatory authorities are promoting adaptive design features in order to support "more efficient trial design," which was defined as one of the goals of the US Food and Drug Administration's Critical Path Initiative.1

 

© 2022 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy